Cargando…
The effectiveness of pancreatic enzyme replacement therapy for malabsorption in advanced pancreatic cancer, a pilot study
Advanced adenocarcinoma of the pancreas has a globally poor prognosis. One of the characteristic features of pancreatic cancer (PC) is pancreatic exocrine insufficiency (PEI). This leads to a malabsorption syndrome and subsequent digestive symptoms. Given the high prevalence of PEI and malabsorption...
Autores principales: | Landers, Amanda, Brown, Helen, Strother, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378466/ https://www.ncbi.nlm.nih.gov/pubmed/30799929 http://dx.doi.org/10.1177/1178224218825270 |
Ejemplares similares
-
Recruitment of participants with pancreatic cancer to a mixed media study for optimal recruitment in an Australasian survey of pancreatic enzyme replacement
por: Landers, Amanda, et al.
Publicado: (2023) -
Pancreatic Enzyme Replacement Therapy in Pancreatic Cancer
por: Pezzilli, Raffaele, et al.
Publicado: (2020) -
Total pancreatic lipomatosis with malabsorption syndrome
por: Anand, Rama, et al.
Publicado: (2011) -
Pancreatic Enzyme Replacement Therapy in Cystic Fibrosis
por: Freswick, Peter N., et al.
Publicado: (2022) -
Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients
por: Barkin, Jodie A., et al.
Publicado: (2019)